~ Mumps in Pregnancy ~
§ Background:
Incidence in pregnancy
has been estimated to be from 0.8 to 10 cases per
10000 pregnancies.
The significance of
this disease in obstetrics rests with its effects on the fetus.
§ Diagnosis:
Mainly based on
clinical history and presentation:
close contact with a person who has acquired mumps
typical viral prodrome of fever, anorexia, malaise, and
myalgia
infection and swelling of the glands, which will resolve in 1
week or less
§ Maternal and fetal effects:
Maternal effects:
¶ Typically mumps is not
appreciably more severe in pregnancy women
than it is in other adult women.
¶ Parotitis, usually
bilateral.
¶ Mastitis and
thyroiditis can occur in postpartum women, but not any more
frequently than nonpregnant women.
¶ Rare complications:
aseptic meningitis, myocarditis, nephritis, or arthritis.
Embryonic/Fetal
effects:
¶ Spontaneous abortion,
when acquiring during first trimester
¶ There are no evidence
of increased risks of prematurity and congenital
anomalies while having mumps in pregnant women. Presence of
maternal
mumps infections is not an indication for therapeutic
abortion.
¶ Congenital mumps or
postnatally-acquired perinatal mumps: rare
§ Treatment and prevention:
Symptomatic
management, such as analgesics, antipyretics, cold packs, etc.
Immunization (live
attenuated mumps virus vaccine):
¶ Two-dose schedule for
child
¶ Contraindications:
infants less than 1-year-old, pregnant women,
immunocompromised patients
§ References:
1. Mumps in pregnancy. R. David Miller, MD, and W. David
Hager, MD.
Contemporary OB/GYN Feb. 2000: 119-123
Filename: Mumps in Pregnancy
|